chr19-13286878-G-A

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 1P and 7B. PP2BP4BP6_ModerateBS2

The NM_001127222.2(CACNA1A):​c.3178C>T​(p.Pro1060Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000479 in 1,461,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000048 ( 0 hom. )

Consequence

CACNA1A
NM_001127222.2 missense

Scores

1
7
11

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 3.66
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CACNA1A. . Gene score misZ: 5.7845 (greater than the threshold 3.09). Trascript score misZ: 3.9354 (greater than threshold 3.09). The gene has 137 curated pathogenic missense variants (we use a threshold of 10). The gene has 132 curated benign missense variants. GenCC has associacion of the gene with benign paroxysmal torticollis of infancy, developmental and epileptic encephalopathy, 42, undetermined early-onset epileptic encephalopathy, episodic ataxia type 2, familial or sporadic hemiplegic migraine, spinocerebellar ataxia type 6, Lennox-Gastaut syndrome, migraine, familial hemiplegic, 1.
BP4
Computational evidence support a benign effect (MetaRNN=0.39107397).
BP6
Variant 19-13286878-G-A is Benign according to our data. Variant chr19-13286878-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 476250.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CACNA1ANM_001127222.2 linkc.3178C>T p.Pro1060Ser missense_variant 20/47 ENST00000360228.11 NP_001120694.1 O00555-8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CACNA1AENST00000360228.11 linkc.3178C>T p.Pro1060Ser missense_variant 20/471 NM_001127222.2 ENSP00000353362.5 O00555-8
CACNA1AENST00000638029.1 linkc.3190C>T p.Pro1064Ser missense_variant 20/485 ENSP00000489829.1 A0A087WW63
CACNA1AENST00000573710.7 linkc.3184C>T p.Pro1062Ser missense_variant 20/475 ENSP00000460092.3 A0A1C7CYY9
CACNA1AENST00000635727.1 linkc.3181C>T p.Pro1061Ser missense_variant 20/475 ENSP00000490001.1 A0A1B0GU81
CACNA1AENST00000637769.1 linkc.3181C>T p.Pro1061Ser missense_variant 20/471 ENSP00000489778.1 A0A1B0GTN7
CACNA1AENST00000636012.1 linkc.3181C>T p.Pro1061Ser missense_variant 20/465 ENSP00000490223.1 A0A1B0GUS3
CACNA1AENST00000637736.1 linkc.3040C>T p.Pro1014Ser missense_variant 19/465 ENSP00000489861.1 A0A1B0GTW2
CACNA1AENST00000636389.1 linkc.3181C>T p.Pro1061Ser missense_variant 20/475 ENSP00000489992.1 A0A1B0GU74
CACNA1AENST00000637432.1 linkc.3190C>T p.Pro1064Ser missense_variant 20/485 ENSP00000490617.1 O00555-2
CACNA1AENST00000636549.1 linkc.3181C>T p.Pro1061Ser missense_variant 20/485 ENSP00000490578.1 B5TYJ1
CACNA1AENST00000637927.1 linkc.3184C>T p.Pro1062Ser missense_variant 20/475 ENSP00000489715.1 A0A1B0GTI4
CACNA1AENST00000635895.1 linkc.3181C>T p.Pro1061Ser missense_variant 20/475 ENSP00000490323.1 A0A384DVW2
CACNA1AENST00000638009.2 linkc.3181C>T p.Pro1061Ser missense_variant 20/471 ENSP00000489913.1 O00555-3
CACNA1AENST00000637276.1 linkc.3181C>T p.Pro1061Ser missense_variant 20/465 ENSP00000489777.1 O00555-5

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD3 exomes
AF:
0.0000162
AC:
4
AN:
246176
Hom.:
0
AF XY:
0.00000745
AC XY:
1
AN XY:
134248
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000479
AC:
7
AN:
1461356
Hom.:
0
Cov.:
35
AF XY:
0.00000275
AC XY:
2
AN XY:
726980
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000112
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
Cov.:
31
Bravo
AF:
0.0000113

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJul 17, 2023- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.027
T
BayesDel_noAF
Uncertain
-0.050
CADD
Uncertain
24
DANN
Uncertain
0.98
DEOGEN2
Benign
0.14
.;T;T;.;.;.;.;.;.;T;.;.;.;T;.
Eigen
Benign
-0.0021
Eigen_PC
Benign
0.14
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.90
D;D;D;D;D;D;D;D;.;D;D;D;D;D;D
M_CAP
Pathogenic
0.57
D
MetaRNN
Benign
0.39
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.10
D
MutationAssessor
Benign
1.6
.;.;.;.;L;.;.;.;.;.;.;.;L;.;.
PrimateAI
Benign
0.45
T
PROVEAN
Uncertain
-2.9
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Uncertain
0.35
Sift
Benign
0.11
.;T;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
0.28
T;T;.;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.52
MutPred
0.23
.;.;Loss of catalytic residue at P1060 (P = 0.0101);Loss of catalytic residue at P1060 (P = 0.0101);Loss of catalytic residue at P1060 (P = 0.0101);.;Loss of catalytic residue at P1060 (P = 0.0101);.;.;Loss of catalytic residue at P1060 (P = 0.0101);Loss of catalytic residue at P1060 (P = 0.0101);.;Loss of catalytic residue at P1060 (P = 0.0101);.;Loss of catalytic residue at P1060 (P = 0.0101);
MVP
0.81
MPC
0.085
ClinPred
0.44
T
GERP RS
5.2
Varity_R
0.12
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs969592968; hg19: chr19-13397692; API